{"id":880063,"date":"2025-08-28T08:47:36","date_gmt":"2025-08-28T12:47:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/"},"modified":"2025-08-28T08:47:36","modified_gmt":"2025-08-28T12:47:36","slug":"oncolytics-biotech-announces-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/","title":{"rendered":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">SAN DIEGO<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 28, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Oncolytics Biotech<sup>\u00ae<\/sup>\u00a0Inc. (Nasdaq: ONCY) (&#8220;Oncolytics&#8221; or the &#8220;Company&#8221;), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO <span class=\"xn-person\">Jared Kelly<\/span> will be meeting with institutional investors at the H.C. Wainwright 27<sup>th<\/sup> Annual Global Investment Conference\u00a0and the Lake Street Capital Markets 9<sup>th<\/sup> Annual Best Ideas Growth Conference. Additional details for both of these events can be found below.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg\" title=\"Oncolytics Biotech\u00ae Inc. Logo (PRNewsfoto\/Oncolytics Biotech\u00ae Inc.)\" alt=\"Oncolytics Biotech\u00ae Inc. Logo (PRNewsfoto\/Oncolytics Biotech\u00ae Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Event: <\/b>H.C. Wainwright 27<sup>th<\/sup> Annual Global Investment Conference<br \/><b>Date: <\/b>Tuesday and <span class=\"xn-chron\">Wednesday, September 9<\/span> &amp; 10, 2025<br \/><b>Location: <\/b>Lotte New York Palace Hotel, <span class=\"xn-location\">New York, NY<\/span><\/p>\n<p>\n        <b>Event: <\/b>Lake Street Capital Markets 9<sup>th<\/sup> Annual Best Ideas Growth Conference<br \/><b>Date: <\/b><span class=\"xn-chron\">Thursday, September 11, 2025<\/span><br \/><b>Location: <\/b>The Yale Club, <span class=\"xn-location\">New York, NY<\/span><\/p>\n<p>Company management will be participating in one-on-one investor meetings at the conferences. To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright or Lake Street Capital Markets representative, or email <a href=\"mailto:jpatton@oncolytics.ca\" target=\"_blank\" rel=\"nofollow\">jpatton@oncolytics.ca<\/a>.\u00a0<\/p>\n<p>\n        <b>About Oncolytics Biotech Inc.<\/b>\n      <\/p>\n<p>Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated promising results in multiple first-line pancreatic cancer studies, two randomized Phase 2 studies in metastatic breast cancer, and early-phase studies in anal and colorectal cancer. It induces anti-cancer immune responses by converting immunologically &#8220;cold&#8221; tumors &#8220;hot&#8221; through the activation of innate and adaptive immune responses.<\/p>\n<p>The Company is advancing pelareorep in combination with chemotherapy and\/or checkpoint inhibitors in metastatic pancreatic and breast cancers, both of which have received Fast Track designation from the FDA, and other gastrointestinal tumors. Oncolytics is actively pursuing strategic partnerships to accelerate development and maximize commercial impact. For more about Oncolytics, please visit:\u00a0<a href=\"http:\/\/www.oncolyticsbiotech.com\/\" target=\"_blank\" rel=\"nofollow\">www.oncolyticsbiotech.com<\/a>\u00a0or follow the Company on social media on <a href=\"https:\/\/www.linkedin.com\/company\/oncolytics-biotech-inc.\/\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>\u00a0and on X @<a href=\"https:\/\/x.com\/oncolytics\" target=\"_blank\" rel=\"nofollow\">oncolytics<\/a>.<\/p>\n<p>\n        <b>Company Contact\u00a0<br \/><\/b><br \/>\n        <span class=\"xn-person\">Jon Patton<\/span><br \/>\n        <br \/>Director of IR &amp; Communication<br \/><a href=\"mailto:jpatton@oncolytics.ca\" target=\"_blank\" rel=\"nofollow\">jpatton@oncolytics.ca<\/a>\u00a0<\/p>\n<p>\n        <b>Investor Relations for Oncolytics<br \/><\/b><br \/>\n        <span class=\"xn-person\">Mike Moyer<\/span><br \/>\n        <br \/>LifeSci Advisors<br \/>+1-617-308-4306<br \/><a href=\"mailto:mmoyer@lifesciadvisors.com\" target=\"_blank\" rel=\"nofollow\">mmoyer@lifesciadvisors.com<\/a>\u00a0<\/p>\n<p>\n        <b>Media Contact for Oncolytics<br \/><\/b><br \/>\n        <span class=\"xn-person\">Owen Blaschak<\/span><br \/>\n        <br \/>LifeSci Communications<br \/><a href=\"mailto:oblaschak@lifescicomms.com\" target=\"_blank\" rel=\"nofollow\">oblaschak@lifescicomms.com<\/a>\u00a0<\/p>\n<p>Logo: <a href=\"https:\/\/mma.prnewswire.com\/media\/2408622\/5481159\/Oncolytics_Biotech_Inc_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/2408622\/5481159\/Oncolytics_Biotech_Inc_Logo.jpg<\/a><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN60873&amp;sd=2025-08-28\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september-302540829.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september-302540829.html<\/a><\/p>\n<p>SOURCE  Oncolytics Biotech\u00ae Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN60873&amp;Transmission_Id=202508280830PR_NEWS_USPR_____LN60873&amp;DateId=20250828\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO , Aug. 28, 2025 \/PRNewswire\/ &#8212; Oncolytics Biotech\u00ae\u00a0Inc. (Nasdaq: ONCY) (&#8220;Oncolytics&#8221; or the &#8220;Company&#8221;), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO Jared Kelly will be meeting with institutional investors at the H.C. Wainwright 27th Annual Global Investment Conference\u00a0and the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference. Additional details for both of these events can be found below. Event: H.C. Wainwright 27th Annual Global Investment ConferenceDate: Tuesday and Wednesday, September 9 &amp; 10, 2025Location: Lotte New York Palace Hotel, New York, NY Event: Lake Street Capital Markets 9th Annual Best Ideas Growth ConferenceDate: Thursday, September 11, 2025Location: The Yale Club, New York, NY Company management will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-880063","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO , Aug. 28, 2025 \/PRNewswire\/ &#8212; Oncolytics Biotech\u00ae\u00a0Inc. (Nasdaq: ONCY) (&#8220;Oncolytics&#8221; or the &#8220;Company&#8221;), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO Jared Kelly will be meeting with institutional investors at the H.C. Wainwright 27th Annual Global Investment Conference\u00a0and the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference. Additional details for both of these events can be found below. Event: H.C. Wainwright 27th Annual Global Investment ConferenceDate: Tuesday and Wednesday, September 9 &amp; 10, 2025Location: Lotte New York Palace Hotel, New York, NY Event: Lake Street Capital Markets 9th Annual Best Ideas Growth ConferenceDate: Thursday, September 11, 2025Location: The Yale Club, New York, NY Company management will &hellip; Continue reading &quot;Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T12:47:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September\",\"datePublished\":\"2025-08-28T12:47:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":365,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2408622\\\/Oncolytics_Biotech_Inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/\",\"name\":\"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2408622\\\/Oncolytics_Biotech_Inc_Logo.jpg\",\"datePublished\":\"2025-08-28T12:47:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2408622\\\/Oncolytics_Biotech_Inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2408622\\\/Oncolytics_Biotech_Inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk","og_description":"PR Newswire SAN DIEGO , Aug. 28, 2025 \/PRNewswire\/ &#8212; Oncolytics Biotech\u00ae\u00a0Inc. (Nasdaq: ONCY) (&#8220;Oncolytics&#8221; or the &#8220;Company&#8221;), a clinical-stage immunotherapy company developing pelareorep, will participate in two investor conferences next month. CEO Jared Kelly will be meeting with institutional investors at the H.C. Wainwright 27th Annual Global Investment Conference\u00a0and the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference. Additional details for both of these events can be found below. Event: H.C. Wainwright 27th Annual Global Investment ConferenceDate: Tuesday and Wednesday, September 9 &amp; 10, 2025Location: Lotte New York Palace Hotel, New York, NY Event: Lake Street Capital Markets 9th Annual Best Ideas Growth ConferenceDate: Thursday, September 11, 2025Location: The Yale Club, New York, NY Company management will &hellip; Continue reading \"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-28T12:47:36+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September","datePublished":"2025-08-28T12:47:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/"},"wordCount":365,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/","name":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg","datePublished":"2025-08-28T12:47:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2408622\/Oncolytics_Biotech_Inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-announces-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oncolytics Biotech\u00ae Announces Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/880063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=880063"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/880063\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=880063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=880063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=880063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}